Maternal inflammatory bowel disease has short and long-term effects on the health of their offspring: A multicenter study in Israel
Authors:
- Iris DotanIDIris Dotan
- Arik AlperAAArik Alper
- Daniel RachmilewitzDRDaniel Rachmilewitz
- Eran IsraeliEIEran Israeli
- Shmuel OdesSOShmuel Odes
- Irit ChermeshICIrit Chermesh
- Timna NaftaliTNTimna Naftali
- Gerald FraserGFGerald Fraser
- Ariella Bar-Gil ShitritASAriella Bar-Gil Shitrit
- Vardit PelesVPVardit Peles
- Shimon ReifSRShimon Reif
- 1 August 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 7 (7) , 542-550
Abstract
There are concerns about the effect of inflammatory bowel diseases (IBD) on fertility, pregnancy and pregnancy outcomes, but no long-term data on the health of offspring born to IBD mothers. The aims were to assess the short- and long-term effects of maternal IBD on the morbidity and development of their offspring. Female IBD patients and controls completed questionnaires on their pregnancy outcome, and their offspring's short- and long-term health and development. IBD and control mothers (159 and 175, respectively) were recruited. Medical data of 412 IBD and 417 control offspring were recorded. IBD mothers had significantly more singleton pregnancies, their offspring's birth weight was significantly lower, and they breastfed significantly less compared to controls (P=0.028, 0.007, and <0.0001, respectively). There were significantly more congenital anomalies (mainly limb deformities) among the IBD offspring (P<0.035). Offspring born post-maternal IBD diagnosis, compared to pre-diagnosis, tended to have more neurodevelopmental problems (e.g., gross motor delay, P=0.03). IBD was significantly more prevalent in the offspring of IBD mothers, while allergies and atopic dermatitis were more frequent in offspring of control mothers. More offspring of IBD mothers taking medications during pregnancy were born preterm and had lower birth weights compared to offspring of IBD mothers not taking medications during pregnancy. Children of mothers taking steroids had the lowest birth weights, compared to those of IBD mothers taking 5ASAs or immunomodulators. Maternal IBD affects pregnancy and the offspring's immediate and long-term morbidity, specifically, congenital anomalies and neurodevelopmental problems.Keywords
This publication has 25 references indexed in Scilit:
- Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapyInflammatory Bowel Diseases, 2011
- New insights into nutrition and cognitive neuroscienceProceedings of the Nutrition Society, 2009
- Early pregnancy azathioprine use and pregnancy outcomesBirth Defects Research Part A: Clinical and Molecular Teratology, 2009
- Pregnancy Outcomes in Women With Inflammatory Bowel Disease: A Large Community-Based Study From Northern CaliforniaGastroenterology, 2007
- A meta-analysis on the influence of inflammatory bowel disease on pregnancyGut, 2006
- Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registriesAmerican Journal of Gastroenterology, 1998
- Breast-feeding and maternal smoking in the etiology of Crohn's disease and ulcerative colitis in childhoodAnnals of Epidemiology, 1993
- Role of infant feeding practices in development of Crohn's disease in childhood.BMJ, 1989
- Pregnancy in Ulcerative ColitisScandinavian Journal of Gastroenterology, 1983
- The Denver Developmental Screening TestThe Journal of Pediatrics, 1967